Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain

Brain Research

Volumn 1286, Issue , 2009, Pages 32-41

  Bhide, Nirmal S ^a   Lipton, Jack W ^b   Cunningham, Jacobi I ^c   Yamamoto, Bryan K ^c   Gudelsky, Gary A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

MDMA; Neuroprotection; Neurotoxicity; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; METHAMPHETAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; ENVIRONMENTAL TEMPERATURE; HIPPOCAMPUS; HYPERTHERMIA; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BLOTTING, WESTERN; BRAIN; DOPAMINE; DRUG TOLERANCE; FEVER; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPROTECTIVE AGENTS; RATS; RNA-BINDING PROTEINS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

ANIMALIA; RATTUS;

EID: 67849133763     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.042     Document Type: Article

References (26)

1. Baumann M.H., Clark R.D., Franken F.H., Rutter J.J., and Rothman R.B. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience 152 (2008) 773-784
2. Broening H.W., Bowyer J.F., and Slikker W. Age-dependent sensitivity of long-term effects of the serotonergic neurotoxicant, 3,4-methylenedioxy-methamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J. Pharmacol. Exp. Ther. 275 (1995) 325-333
3. Campbell N.G., Koprich J.B., Kanaan N.M., and Lipton J.W. MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment. Neurotoxicol. Teratol. 28 (2006) 459-465
4. Danaceau J.P., Deering C.E., Day J.E., Smeal S.J., Johnson-Davis K.L., Fleckenstein A.E., and Wilkins D.G. Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur. J. Pharmacol. 559 (2007) 46-54
5. Darvesh A.S., and Gudelsky G.A. Evidence for a role of energy dysregulation in the MDMA induced depletion of brain 5-HT. Brain Res. 1056 (2005) 168-175
6. Darvesh A.S., Yamamoto B.K., and Gudelsky G.A. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. J. Pharmacol. Exp. Ther. 312 (2005) 694-701
7. Erives G.V., Lau S.S., and Monks T.J. Accumulation of neurotoxic thioether metabolites of 3,4-(+/-)-methylenedioxymethamphetamine in rat brain. J. Pharmacol. Exp. Ther. 324 (2008) 284-291
8. Escobedo I., Peraile I., Orio L., Colada M.I., and O'shea E. Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain. J. Neurochem. 101 (2007) 1272-1283
9. Farfel G.M., and Seiden L.S. Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J. Pharmacol. Exp. Ther. 272 (1995) 860-867
10. Johnson-Davis K.L., Fleckenstein A.E., and Wilkins D.G. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur. J. Pharmacol. 482 (2003) 151-154
11. Jones D.C., Lau S.S., and Monks T.J. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (HSERT) function and simultaneously stimulate dopamine uptake into HSERT-expressing SK-N-MC cells. J. Pharmacol. Exp. Ther. 311 (2004) 298-306
12. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K., and Kamada T. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528 (1991) 21-24
13. Malberg J.E., Sabol K.E., and Seiden L.S. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J. Pharmacol. Exp. Ther. 278 (1996) 258-267
14. Malberg J.E., and Seiden L.S. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J. Neurosci. 18 (1998) 5086-5094
15. O'Hearn E., Battaglia G., DeSouza E.B., Kuhar M.J., and Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxy-methamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in the forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8 (1988) 2788-2803
16. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), The Academic Press, San Diego
17. Perez-Pinon M.A., Dave K.R., and Raval A.P. Role of reactive oxygen species and protein kinase C in ischemic tolerance in the brain. Antioxid. Redox Signal. 7 (2005) 1150-1157
18. Piper B.J., Fraiman J.B., and Meyer J.S. Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention and serotonin transporter binding. Dev. Psychobiol. 47 (2005) 145-157
19. Piper B.J., Huyen L.V., Safain M.G., Oliver A.J., and Meyer J.S. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine-1A receptor agonist. J. Pharmacol. Exp. Ther. 317 (2006) 838-849
20. Quinton M.S., and Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J. 8 (2005) e337-347
21. Ricaurte G.A., Forno L., Wilson M.A., Delanney L., Irwin I., Molliver M.E., and Langston J.W. (+/-)-3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. J. Am. Med. Assoc. 260 (1988) 51-55
22. Riddle E.L., Kokoshka J.M., Wilkins D.G., Hanson G.R., and Fleckenstein A.E. Tolerance to the neurotoxic effects of methamphetamine in young rats. Eur. J. Pharmacol. 435 (2002) 181-185
23. Schaller B., and Graf R. Cerebral ischemic preconditioning. J. Neurol. 249 (2002) 1503-1511
24. Schmidt C.J. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240 (1987) 1-7
25. Shankaran M., Yamamoto B.K., and Gudelsky G.A. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 385 (1999) 103-110
26. Stone D.M., Hanso G.R., and Gibb J.W. The effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoaminergic systems in the rat brain. Eur. J. Pharmacol. 128 (1986) 41-49